Hôpital Claude Huriez
Lille, France
NCT Number: NCT03261414
The aim of this study will be to show a decrease in postoperative morphine consumption by the practice of perioperative self-hypnosis in patients undergoing laparoscopic ileo-caecal resection for Crohn's disease
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Lille, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A short preanesthetic hypnosis before induction of anesthesia
Standard care before induction of anesthesia
Time frame: During the first 24 postoperative hours
Compare the cumulative morphine consumption during 24 hours postoperative Data from PCA pump and patient medical record
Time frame: between the 24 and the 48 postoperative hours
Compare the cumulative morphine consumption between the 24 and the 48 postoperative hours Data from PCA pump and patient medical record
Time frame: during first 7 postoperative days
Time frame: during first 7 postoperative days
The hypnotics and opioids drug dose will be recorded
Time frame: during first 7 postoperative days
The antiemetic drug dose will be recorded
Time frame: first 24 postoperative hours
PONV risk assessment tool Based on apfel's simplified risk score
Time frame: during first 7 postoperative days
Time frame: during first 7 postoperative days
Ability to drink, to eat, to urinate, to walk
University Hospital, Lille
Other
Prospective Randomized Study Evaluating the Effect of Pre-operative Hypnosis on Anesthesia, Analgesia and Perioperative Stress Laparoscopic Ileo-caecal Resections of Crohn's Disease.
Acronym: HYSTERIA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04757181
Digestive System Diseases, Gastroenteritis
Worcester, Massachusetts, United States
View Trial DetailsNCT03938324
Anemia, Anemia, Hemolytic
Durham, North Carolina, United States
View Trial DetailsNCT06094608
Colitis, Colitis, Ulcerative
Ann Arbor, Michigan, United States
View Trial DetailsNCT05809999
Colonic Diseases, Colonic Neoplasms
Edmonton, Alberta, Canada
View Trial Details